Barron's Stem Cell Stocks

Description:

From Barron's 5-7-07

"If wall street believes in following the money, much of its own private cash has gone to stem cells lately (see Wealthy Individuals, States Fund What Bush Won't). And private-equity money could well follow as the science gathers momentum. "There's a whole developing field of socially responsible investing, and I think it hasn't yet looked at critically necessary medicine," says Robert Klein, the real-estate developer who was the driving force behind California's decision to fund stem-cell research. Within three years, more money should come from venture-capital investors, pensions with a social mandate, and the growing pool of socially responsible funds, Klein says."

Most Viewed Portfolios

View All

Articles

4 Stocks Under $10 Making Big Moves

05.30.12 | 03:01 PM

 WINDERMERE, Fla. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest p...

4 Stocks Under $5 Soaring Higher

05.30.12 | 02:56 PM

WINDERMERE, Fla. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percent...

More Articles
blog comments powered by Disqus
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter